These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer. Devetzi M; Trangas T; Scorilas A; Xynopoulos D; Talieri M Thromb Haemost; 2013 Apr; 109(4):716-25. PubMed ID: 23224034 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer. Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713 [TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer. Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411 [TBL] [Abstract][Full Text] [Related]
6. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma. Vakrakou A; Devetzi M; Papachristopoulou G; Malachias A; Scorilas A; Xynopoulos D; Talieri M Biol Chem; 2014 Sep; 395(9):1105-17. PubMed ID: 25153391 [TBL] [Abstract][Full Text] [Related]
7. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. Alexopoulou DK; Papadopoulos IN; Scorilas A Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues. Yousef GM; Obiezu CV; Jung K; Stephan C; Scorilas A; Diamandis EP Urology; 2002 Oct; 60(4):714-8. PubMed ID: 12385949 [TBL] [Abstract][Full Text] [Related]
10. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: association with kallikrein-related peptidase 7 expression. Talieri M; Devetzi M; Scorilas A; Prezas P; Ardavanis A; Apostolaki A; Karameris A Anticancer Res; 2011 Sep; 31(9):3093-100. PubMed ID: 21868565 [TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker. Korbakis D; Gregorakis AK; Scorilas A Clin Chem; 2009 May; 55(5):904-13. PubMed ID: 19299547 [TBL] [Abstract][Full Text] [Related]
13. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients. Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer. Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135 [TBL] [Abstract][Full Text] [Related]
15. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer. Yousef GM; White NM; Kurlender L; Michael I; Memari N; Robb JD; Katsaros D; Stephan C; Jung K; Diamandis EP Tumour Biol; 2004; 25(5-6):221-7. PubMed ID: 15627884 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967 [TBL] [Abstract][Full Text] [Related]
17. Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Talieri M; Alexopoulou DK; Scorilas A; Kypraios D; Arnogiannaki N; Devetzi M; Patsavela M; Xynopoulos D Tumour Biol; 2011 Aug; 32(4):737-44. PubMed ID: 21487810 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]
19. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. Planque C; de Monte M; Guyetant S; Rollin J; Desmazes C; Panel V; Lemarié E; Courty Y Biochem Biophys Res Commun; 2005 Apr; 329(4):1260-6. PubMed ID: 15766562 [TBL] [Abstract][Full Text] [Related]
20. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact. Talieri M; Devetzi M; Scorilas A; Pappa E; Tsapralis N; Missitzis I; Ardavanis A Tumour Biol; 2012 Aug; 33(4):1075-84. PubMed ID: 22351561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]